BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10574636)

  • 1. Activation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrel.
    Fruzzetti F; De Negri F; Morale M; Ricci C; Ferrini L; Bersi C; Genazzani AR; Carmassi F
    Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):113-8. PubMed ID: 10574636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.
    Winkler UH; Daume E; Sudik R; Oberhoff C; Bier U; Hallmann C; Andreas JO; Schindler AE
    Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):145-54. PubMed ID: 10574640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR; Skouby SO; Sidelmann J; Jespersen J
    Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
    Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A
    Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.
    Kluft C; Endrikat J; Mulder SM; Gerlinger C; Heithecker R
    Contraception; 2006 Apr; 73(4):336-43. PubMed ID: 16531162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of low-dose oral contraceptive regulon-Gedeon Richter on some hemostatic variables].
    Uchikova E; Ledzhev I; Milchev N; Tsvetkova T
    Akush Ginekol (Sofiia); 2004; 43(2):58-62. PubMed ID: 15185533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
    Wiegratz I; Stahlberg S; Manthey T; Sänger N; Mittmann K; Lange E; Mellinger U; Kuhl H
    Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the monophase oral contraceptive combination with 20 ug ethinyl estradiol/150 ug desogestrel on haemostasis].
    Uchikova E; Milchev N; Terzhumanov R; Markova D
    Akush Ginekol (Sofiia); 2004; 43(4):29-32. PubMed ID: 15318540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
    Kluft C; Meijer P; LaGuardia KD; Fisher AC
    Contraception; 2008 Feb; 77(2):77-83. PubMed ID: 18226669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives.
    Bremme K; Hamad RR; Berg E; Strandberg K; Stenflo J
    Thromb Res; 2012 Oct; 130(4):636-9. PubMed ID: 22154243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
    Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
    Levine AB; Teppa J; McGough B; Cowchock FS
    Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contraceptive vaginal ring (NuvaRing) and hemostasis: a comparative study.
    Magnusdóttir EM; Bjarnadóttir RI; Onundarson PT; Gudmundsdóttir BR; Geirsson RT; Magnusdóttir SD; Dieben TO
    Contraception; 2004 Jun; 69(6):461-7. PubMed ID: 15157790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins].
    Uchikova E; Batashki I; Milchev N; Mateva N; Markova D; Gŭrova A
    Akush Ginekol (Sofiia); 2006; 45(2):39-43. PubMed ID: 16637303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.